Sarah V. Colonna

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

Eileen Dareng, Jonathan P. Tyrer, Daniel R. Barnes et al. · European Journal of Human Genetics · 2022 · 72 citations · Full text

Medicine, Biostatistics, Oncology +17

Characterization of the Cancer Spectrum in Men With Germline<i>BRCA1</i>and<i>BRCA2</i>Pathogenic Variants

Valentina Silvestri, Goska Leslie, Daniel R. Barnes et al. · JAMA Oncology · 2020 · 67 citations · Full text

Medicine, Genetics, Oncology +17

Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab

Justin Moser, Danli Chen, Siwen Hu‐Lieskovan et al. · Cancer Medicine · 2019 · 61 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma

Justin C. Moser, Guo Wei, Sarah V. Colonna et al. · Acta Oncologica · 2020 · 43 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models

Kimberly A. Kaphingst, Wendy Kohlmann, Rachelle Lorenz Chambers et al. · JAMA Network Open · 2024 · 41 citations · Full text

Life Sciences, Genetics, Oncology +15